Gilder Gagnon Howe & CO LLC Regeneron Pharmaceuticals, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $2.55 Million - $3.13 Million	-5,707 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $461,081 - $586,092	-964 Reduced 14.45%	5,707 $2.76 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $171,051 - $206,677	-314 Reduced 4.5%	6,671 $3.73 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $73,998 - $96,588	-150 Reduced 2.1%	6,985 $4.36 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $2.4 Million - $3.53 Million	7,135 New	7,135 $3.48 Million

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.